GSK Signs Agreement With Russian Firm for Vaccine Manufacture

by Kathy Jones on  November 29, 2010 at 9:13 PM Corporate News   - G J E 4
GlaxoSmithKline (GSK) has announced that it has entered into a partnership with Russian pharmaceutical company, JSC Binnopharm in order to locally manufacture GSK vaccines in the country.
 GSK Signs Agreement With Russian Firm for Vaccine Manufacture
GSK Signs Agreement With Russian Firm for Vaccine Manufacture

According to the agreement, GSK will provide the technological knowhow and supply vaccines while Binnopharm will be responsible for secondary manufacturing processes including filling and packaging of the vaccines.

Some of the GSK vaccines to be manufactured under Binnopharm trademark include the cervical cancer, rotavirus and pneumococcal vaccines with the Russian company also responsible for acquiring approval of their facilities in accordance with international current Good Manufacturing Practice (cGMP) standards.

Announcing the partnership, GSK's Emerging Markets & Asia Pacific's president Abbas Hussain said "This agreement is an example of the flexible approach we are taking to make innovative vaccines more available in emerging markets through local partnerships. GSK has one of the broadest and fastest growing vaccines businesses in the world. This alliance with Binnopharm should ensure that more of these innovative vaccines are made available in Russia to benefit public health."

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like